{"url_path":"/sec/ixhl/8-k/2026-06-10/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-10","source_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-067081-index.html","accession_number":"0001213900-26-067081","cik":"0001873875","ticker":"IXHL","issuer_name":"Incannex Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-067081-index.html","primary_entity_key":"0001873875","primary_entity_name":"Incannex Healthcare Inc."},"word_count":318,"has_tables":true,"body_markdown":"false\n0001873875\n\n0001873875\n\n2026-06-10\n2026-06-10\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n**SECURITIES AND EXCHANGE\nCOMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT**\n\n**Pursuant to Section\n13 or 15(d)**\n\n**of the Securities Exchange\nAct of 1934**\n\n \n\nDate of Report (Date of\nearliest event reported): **June 10, 2026**\n\n \n\n**Incannex Healthcare Inc.**\n\n(Exact name of registrant\nas specified in its charter)\n\n \n\n**Delaware**\n \n**001-41106**\n \n**93-2403210**\n\n(State or other Jurisdiction\n\nof Incorporation)\n \n(Commission File Number)\n \n**(**IRS Employer\n\nIdentification No.)\n\n \n\n**Rialto South Tower**\n\n**Level 23, 525 Collins Street\nMelbourne, VIC 3008 Australia**\n\n \n**Not applicable**\n\n(Address of Principal Executive Offices)\n \n(Zip Code)\n\n \n\nRegistrant’s Telephone\nNumber, including Area Code**: +61 409 840 786**\n\n \n\n**(**Former Name or\nFormer Address, if Changed Since Last Report): **Not Applicable**\n\n \n\nCheck the appropriate\nbox below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following\nprovisions:\n\n \n\n☐\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n☐\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n☐\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n☐\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant to Section\n12(b) of the Act:\n\n \n\n**Title of each class**\n \n**Trading Symbol**\n \n**Name of exchange on which registered**\n\nCommon Stock, $0.0001 par value per share\n \nIXHL\n \nThe Nasdaq Stock Market LLC\n\n \n\nIndicate by check mark\nwhether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter)\nor Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)\n\n \n\nEmerging growth company ☒\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ☐"}